Nexaph peptides represent a novel clinical strategy targeting illness progression. These engineered molecules leverage the distinct properties of short peptide sequences to influence cellular activities involved in swelling, scarring, and neoplasm development. Research indicate their possibility for managing a variety of long-term ailments, offerin